Dynamic Medical Technologies - Asset Resilience Ratio
Dynamic Medical Technologies (4138) has an Asset Resilience Ratio of 18.54% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Dynamic Medical Technologies (4138) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Dynamic Medical Technologies's Asset Resilience Ratio has changed over time. See net asset quality index of Dynamic Medical Technologies to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Dynamic Medical Technologies's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4138 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$579.70 Million | 18.54% |
| Total Liquid Assets | NT$579.70 Million | 18.54% |
Asset Resilience Insights
- Good Liquidity Position: Dynamic Medical Technologies maintains a healthy 18.54% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Dynamic Medical Technologies Industry Peers by Asset Resilience Ratio
Compare Dynamic Medical Technologies's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Dynamic Medical Technologies (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Dynamic Medical Technologies.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 18.54% | NT$579.70 Million ≈ $18.26 Million |
NT$3.13 Billion ≈ $98.51 Million |
-1.87pp |
| 2024-12-31 | 20.41% | NT$613.25 Million ≈ $19.32 Million |
NT$3.00 Billion ≈ $94.65 Million |
-0.33pp |
| 2023-12-31 | 20.75% | NT$638.36 Million ≈ $20.11 Million |
NT$3.08 Billion ≈ $96.94 Million |
-0.94pp |
| 2022-12-31 | 21.69% | NT$581.46 Million ≈ $18.32 Million |
NT$2.68 Billion ≈ $84.47 Million |
+0.28pp |
| 2021-12-31 | 21.41% | NT$492.09 Million ≈ $15.50 Million |
NT$2.30 Billion ≈ $72.42 Million |
+0.53pp |
| 2020-12-31 | 20.88% | NT$447.35 Million ≈ $14.09 Million |
NT$2.14 Billion ≈ $67.51 Million |
-0.19pp |
| 2019-12-31 | 21.07% | NT$468.65 Million ≈ $14.77 Million |
NT$2.22 Billion ≈ $70.08 Million |
+12.15pp |
| 2018-12-31 | 8.92% | NT$180.02 Million ≈ $5.67 Million |
NT$2.02 Billion ≈ $63.61 Million |
-5.39pp |
| 2017-12-31 | 14.31% | NT$330.60 Million ≈ $10.42 Million |
NT$2.31 Billion ≈ $72.78 Million |
-0.74pp |
| 2016-12-31 | 15.05% | NT$341.62 Million ≈ $10.76 Million |
NT$2.27 Billion ≈ $71.49 Million |
-- |
About Dynamic Medical Technologies
Dynamic Medical Technologies Inc., together with its subsidiaries, engages in the sale, maintenance, and marketing of aesthetic lasers and light-based equipment in Taiwan and Hong Kong. It distributes and sells aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The company also provides aesthetician training and clinical operation consultation services. In add… Read more